728 related articles for article (PubMed ID: 17156158)
1. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
[TBL] [Abstract][Full Text] [Related]
2. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
3. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
Yatham LN; Kennedy SH; Schaffer A; Parikh SV; Beaulieu S; O'Donovan C; MacQueen G; McIntyre RS; Sharma V; Ravindran A; Young LT; Young AH; Alda M; Milev R; Vieta E; Calabrese JR; Berk M; Ha K; Kapczinski F
Bipolar Disord; 2009 May; 11(3):225-55. PubMed ID: 19419382
[TBL] [Abstract][Full Text] [Related]
4. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Beaulieu S; Alda M; O'Donovan C; Macqueen G; McIntyre RS; Sharma V; Ravindran A; Young LT; Milev R; Bond DJ; Frey BN; Goldstein BI; Lafer B; Birmaher B; Ha K; Nolen WA; Berk M
Bipolar Disord; 2013 Feb; 15(1):1-44. PubMed ID: 23237061
[TBL] [Abstract][Full Text] [Related]
5. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M
Bipolar Disord; 2018 Mar; 20(2):97-170. PubMed ID: 29536616
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM; Cornelius V; Smith L; Young AH
Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
[TBL] [Abstract][Full Text] [Related]
8. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
10. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
Maina G; Albert U; Rosso G; Bogetto F
J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
13. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
Yatham LN; Chakrabarty T; Bond DJ; Schaffer A; Beaulieu S; Parikh SV; McIntyre RS; Milev RV; Alda M; Vazquez G; Ravindran AV; Frey BN; Sharma V; Goldstein BI; Rej S; O'Donovan C; Tourjman V; Kozicky JM; Kauer-Sant'Anna M; Malhi G; Suppes T; Vieta E; Kapczinski F; Kanba S; Lam RW; Kennedy SH; Calabrese J; Berk M; Post R
Bipolar Disord; 2021 Dec; 23(8):767-788. PubMed ID: 34599629
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics: newer options for mania and maintenance therapy.
Vieta E; Goikolea JM
Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
17. Revised Korean medication algorithm for bipolar disorder.
Jon DI; Bahk WM; Yoon BH; Shin YC; Cho HS; Lee E; Ha K; Kim W; Chung SK; Seo JS; Min KJ
World J Biol Psychiatry; 2009; 10(4 Pt 3):846-55. PubMed ID: 18615367
[TBL] [Abstract][Full Text] [Related]
18. A review of FDA-approved treatment options in bipolar depression.
McIntyre RS; Cha DS; Kim RD; Mansur RB
CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the efficacy of treatments for bipolar depression.
Nierenberg AA
J Clin Psychiatry; 2008; 69 Suppl 5():4-8. PubMed ID: 19265634
[TBL] [Abstract][Full Text] [Related]
20. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]